STANDARD BIOTOOLS INC. (LAB)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue TTM

0 60M 120M 180M Q3 '16: 110.1M Q4 '16: 104.4M Q1 '17: 101M Q2 '17: 96.7M Q3 '17: 99.3M Q4 '17: 101.9M Q1 '18: 101.7M Q2 '18: 104.2M Q3 '18: 108.4M Q4 '18: 113M Q1 '19: 117.8M Q2 '19: 119.6M Q3 '19: 117.1M Q4 '19: 117.2M Q1 '20: 114.7M Q2 '20: 112.6M Q3 '20: 126M Q4 '20: 138.1M Q1 '21: 143.3M Q2 '21: 148.3M Q3 '21: 136.9M Q4 '21: 130.6M Q1 '22: 124.3M Q2 '22: 112M Q3 '22: 109.2M Q4 '22: 97.9M Q1 '23: 96.6M Q2 '23: 105.5M Q3 '23: 105.2M Q4 '23: 106.3M Q1 '24: 126.8M Q2 '24: 121.6M Q3 '24: 118.3M Q4 '24: 114.9M Q1 '25: 89.6M Q2 '25: 88.8M Q3 '25: 86.3M Q4 '25: 85.3M Q1 '26: 86.3M Q2 '26: 84.6M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Gross Profit TTM

0 25M 50M 75M Q4 '18: 61.6M Q1 '19: 65.2M Q2 '19: 67M Q3 '19: 65.2M Q4 '19: 63.9M Q1 '20: 59.9M Q2 '20: 56.4M Q3 '20: 63.2M Q4 '20: 67.7M Q4 '22: 37.1M Q1 '23: 37.1M Q2 '23: 46.3M Q3 '23: 48.2M Q4 '23: 50.4M Q1 '24: 62.3M Q2 '24: 59.1M Q3 '24: 60M Q4 '24: 58M Q1 '25: 44.9M Q2 '25: 45.2M Q3 '25: 42.5M Q4 '25: 42.5M Q1 '26: 42.8M Q2 '26: 42.7M Q2 '19 Q1 '20 Q4 '20 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Income TTM

-150M -100M -50M 0 50M 100M 150M Q3 '16: -69.2M Q4 '16: -73.2M Q1 '17: -71.9M Q2 '17: -70.2M Q3 '17: -67.3M Q4 '17: -58.4M Q1 '18: -53.5M Q2 '18: -49.8M Q3 '18: -45.8M Q4 '18: -48.2M Q1 '19: -49.7M Q2 '19: -51.6M Q3 '19: -53.8M Q4 '19: -51.8M Q1 '20: -52.6M Q2 '20: -51.7M Q3 '20: -43.3M Q4 '20: -51M Q1 '21: -55.4M Q2 '21: -59M Q3 '21: -73.1M Q4 '21: -67.5M Q1 '22: -75.6M Q2 '22: -96.9M Q3 '22: -106.4M Q4 '22: -116.2M Q1 '23: -105.3M Q2 '23: -84.2M Q3 '23: -76.3M Q4 '23: -76.6M Q1 '24: -120.2M Q2 '24: -133M Q3 '24: -138.5M Q4 '24: -143.2M Q1 '25: -110M Q2 '25: -105.4M Q3 '25: -111.7M Q4 '25: -110.2M Q1 '26: -95.8M Q2 '26: -95.5M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Net Income TTM

-210M -140M -70M 0 70M 140M 210M Q3 '16: -71.2M Q4 '16: -76M Q1 '17: -73.3M Q2 '17: -71.6M Q3 '17: -67.8M Q4 '17: -60.5M Q1 '18: -56.6M Q2 '18: -55.9M Q3 '18: -54.7M Q4 '18: -59M Q1 '19: -71.2M Q2 '19: -68.7M Q3 '19: -66.9M Q4 '19: -64.8M Q1 '20: -55.3M Q2 '20: -54.6M Q3 '20: -47.7M Q4 '20: -53M Q1 '21: -55.9M Q2 '21: -60M Q3 '21: -67.8M Q4 '21: -59.2M Q1 '22: -116.7M Q2 '22: -163.1M Q3 '22: -178.7M Q4 '22: -190.1M Q1 '23: -130.7M Q2 '23: -84.2M Q3 '23: -75.7M Q4 '23: -74.7M Q1 '24: -90M Q2 '24: -118.6M Q3 '24: -124.6M Q4 '24: -138.9M Q1 '25: -132.8M Q2 '25: -120.5M Q3 '25: -128.3M Q4 '25: -74.9M Q1 '26: 78.2M Q2 '26: 84.9M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Cost of Revenue TTM

0 25M 50M 75M Q4 '18: 51.3M Q1 '19: 52.6M Q2 '19: 52.6M Q3 '19: 51.9M Q4 '19: 53M Q4 '22: 60.9M Q1 '23: 59.5M Q2 '23: 59.2M Q3 '23: 57M Q4 '23: 55.9M Q1 '24: 64.5M Q2 '24: 62.5M Q3 '24: 58.3M Q4 '24: 56.9M Q1 '25: 44.7M Q2 '25: 43.7M Q3 '25: 43.8M Q4 '25: 42.8M Q1 '26: 43.5M Q2 '26: 41.9M Q1 '19 Q4 '19 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Cash Flow TTM

-150M -100M -50M 0 50M 100M 150M Q3 '16: -32.8M Q4 '16: -39.1M Q1 '17: -39.8M Q2 '17: -40.8M Q3 '17: -35.5M Q4 '17: -24.1M Q1 '18: -31.8M Q2 '18: -27.8M Q3 '18: -23.9M Q4 '18: -25.2M Q1 '19: -29.2M Q2 '19: -29.8M Q3 '19: -30.3M Q4 '19: -35.2M Q1 '20: -19.4M Q2 '20: -17.2M Q3 '20: -17.2M Q4 '20: -15.4M Q1 '21: -24M Q2 '21: -35.9M Q3 '21: -40.8M Q4 '21: -44.1M Q1 '22: -46.8M Q2 '22: -62.1M Q3 '22: -77.2M Q4 '22: -89.4M Q1 '23: -82.3M Q2 '23: -61.6M Q3 '23: -48.4M Q4 '23: -43.3M Q1 '24: -97.3M Q2 '24: -127M Q3 '24: -143.5M Q4 '24: -143.5M Q1 '25: -111.3M Q2 '25: -92.9M Q3 '25: -87.2M Q4 '25: -74.3M Q1 '26: -90.7M Q2 '26: -80.3M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Free Cash Flow TTM

-180M -120M -60M 0 60M 120M 180M Q3 '16: -38.6M Q4 '16: -44.2M Q1 '17: -44.4M Q2 '17: -44M Q3 '17: -37.6M Q4 '17: -25.7M Q1 '18: -32.7M Q2 '18: -28.7M Q3 '18: -24.4M Q4 '18: -25.6M Q1 '19: -29.7M Q2 '19: -30.7M Q3 '19: -32.4M Q4 '19: -37.7M Q1 '20: -22.7M Q2 '20: -20.7M Q3 '20: -19.7M Q4 '20: -28.1M Q1 '21: -42.6M Q2 '21: -58M Q3 '21: -64.3M Q4 '21: -57.3M Q1 '22: -54M Q2 '22: -66M Q3 '22: -80.7M Q4 '22: -93.2M Q1 '23: -86.2M Q2 '23: -65.5M Q3 '23: -51.9M Q4 '23: -46.1M Q1 '24: -99.9M Q2 '24: -130.7M Q3 '24: -148.5M Q4 '24: -151.8M Q1 '25: -123.9M Q2 '25: -105.5M Q3 '25: -98.4M Q4 '25: -82.6M Q1 '26: -94.5M Q2 '26: -82.6M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 150M 300M 450M Q2 '20: 70.9M Q3 '20: 72.5M Q1 '21: 74.7M Q2 '21: 75.5M Q3 '21: 76.3M Q1 '22: 77M Q2 '22: 77.8M Q3 '22: 78.9M Q1 '23: 79.1M Q2 '23: 78.7M Q3 '23: 79.2M Q1 '24: 294.1M Q2 '24: 372.3M Q3 '24: 371.5M Q1 '25: 378.2M Q2 '25: 380.5M Q3 '25: 382.6M Q1 '26: 388.2M Q2 '26: 390.9M Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-2.70 -1.80 -0.90 0.00 0.90 1.80 2.70 Q3 '16: -2.46 Q4 '16: -2.62 Q1 '17: -2.52 Q2 '17: -2.46 Q3 '17: -2.24 Q4 '17: -1.90 Q1 '18: -1.65 Q2 '18: -1.49 Q3 '18: -1.41 Q4 '18: -1.50 Q1 '19: -1.60 Q2 '19: -1.38 Q3 '19: -1.19 Q4 '19: -1.01 Q1 '20: -0.80 Q2 '20: -0.78 Q3 '20: -0.67 Q4 '20: -0.74 Q1 '21: -0.76 Q2 '21: -0.81 Q3 '21: -0.91 Q4 '21: -0.78 Q1 '22: -1.52 Q2 '22: -2.11 Q3 '22: -2.30 Q4 '22: -2.44 Q1 '23: -1.66 Q2 '23: -1.06 Q3 '23: -0.96 Q4 '23: -0.95 Q1 '24: -1.01 Q2 '24: -0.91 Q3 '24: -0.71 Q4 '24: -0.54 Q1 '25: -0.34 Q2 '25: -0.31 Q3 '25: -0.33 Q4 '25: -0.20 Q1 '26: 0.20 Q2 '26: 0.22 Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.